Loading company…
Reen-agr Biotechnology develops bacteriophage products and antimicrobial control solutions.
Reen-agr Biotechnology develops bacteriophage-based products and technical solutions for animal health, crop protection, food safety, and selected medical markets. The company is based in Wuhan, China, and raised pre-Series B funding in December 2025 led by Guosen H&S, with participation from TigerYeah Capital. It plans to expand research and commercialization of engineered phages and related products.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in